Zoloft During Pregnancy Linked to Increased Heart Defects Risk
Women who use the antidepressant Zoloft during pregnancy may face an increased risk of giving birth to a child with serious heart defects, according to the law firm of Hissey Kientz, LLP. Women who used Zoloft and gave birth to a child with heart defects or other birth defects may be eligible to file a lawsuit and receive compensation for their injuries.
Austin, TX (PRWEB) March 16, 2012
Women who use the antidepressant Zoloft during pregnancy may face an increased risk of giving birth to a child with serious heart defects, according to Hissey Kientz, LLP. Multiple studies have warned about the risk of congenital heart defects and other birth defects linked to taking Zoloft while pregnant. Women who used Zoloft and gave birth to a child with heart defects or other birth defects may be eligible to file a lawsuit and receive compensation for their injuries.
Some of the most commonly reported heart defects among the children whose mothers took Zoloft during pregnancy include ventricular outflow defects and septal defects, according to a study published by the New England Journal of Medicine. The study found that the use of Zoloft during the first trimester of pregnancy doubled the risk of giving birth to a child with these heart defects compared to other antidepressants.
Studies published by the NEJM and BMJ have found that taking Zoloft during the third trimester can also increase the risk of a condition known as persistent pulmonary hypertension of the newborn (PPHN). Women who took Zoloft before the eighth week of pregnancy also faced an increased risk of giving birth to a child with PPHN compared to women who took other antidepressants, the BMJ study found.
The NEJM and BMJ studies also identified other heart defects that may be linked to the use of Zoloft, including coarctation of the aorta, transposition of the greater arteries, Tetralogy of Fallot, patent ductus arteriosus (PDA), bicuspid aortic valve, tricuspid stenosis, cleft mitral valve and cardiomyopathy.
Based on research examining the link between Zoloft and heart defects, the Food and Drug Administration has issued a warning about the potential side effects of taking the drug while pregnant. The agency advised women to talk with their doctors about the relative risks of birth defects from Zoloft in order to determine whether they should discontinue the use of the drug during their pregnancy.
Dozens of women have already filed Zoloft lawsuits (E.D. Pa. 11-5702) after their child was born with heart defects or other birth defects. Patients who want to learn more about filing a lawsuit may wish to speak with a Zoloft lawyer for more information.
If you or a loved one took Zoloft during pregnancy and gave birth to a child with heart defects or other congenital birth defects, you may be eligible to file a lawsuit. For a free legal consultation, contact the lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by email at info(at)hkllp(dot)com.
To learn more about Zoloft and heart defects, visit our online legal information resource at http://www.zoloftbirthdefectslawyers.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/3/prweb9277535.htm